Whitehawk Therapeutics, Inc.
WHWK
$3.92
$0.123.16%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 67.66% | 74.68% | 84.08% | 140.12% | 3.15% |
| Total Depreciation and Amortization | -59.07% | -34.21% | -10.70% | 10.50% | 14.20% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -888.62% | -815.70% | -799.37% | -820.72% | 7.08% |
| Change in Net Operating Assets | 131.90% | 69.62% | -287.98% | -76.49% | -77.73% |
| Cash from Operations | -63.62% | -75.93% | -89.59% | 10.77% | 0.19% |
| Capital Expenditure | 66.63% | 67.69% | 71.01% | 56.13% | 58.36% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -430.81% | -613.11% | -83.17% | -62.54% | -69.19% |
| Cash from Investing | -52.82% | -47.97% | 350.17% | 68.08% | -69.71% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 68,445.89% | 48,026.92% | 47,568.57% | 20,855.86% | -69.96% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -35,531.25% | -11,076.47% | -4,353.13% | -2,740.00% | 90.00% |
| Cash from Financing | 72,496.92% | 60,029.94% | 115,026.83% | 30,854.87% | -60.12% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 125.82% | 119.16% | 483.87% | 780.33% | -243.36% |